Evidence map›Paper›PMID 32109367›Full record

ArticleStem cell reports2020

Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.

Charlene Smith-Geater, Sarah J Hernandez, Ryan G Lim, Miriam Adam, Jie Wu, Jennifer T Stocksdale, Brook T Wassie, Maxwell Philip Gold, Keona Q Wang, Ricardo Miramontes and 7 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Excess Wnt in neurological disease.The Biochemical journal · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Poly ADP-ribose signaling is dysregulated in Huntington disease.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Charlene Smith-GeaterDepartment of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA 92697, USA.
Sarah J HernandezDepartment of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
Ryan G LimDepartment of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
Miriam AdamDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Jie WuDepartment of Biological Chemistry, University of California Irvine, Irvine, CA 92617, USA.
Jennifer T StocksdaleDepartment of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
Brook T WassieLeadCrunch, San Diego, CA 92101, USA.
Maxwell Philip GoldDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Keona Q WangDepartment of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
Ricardo MiramontesDepartment of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
Lexi KopanDepartment of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
Iliana OrellanaDepartment of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
Shona JoyNeural Stem Cell Institute, Rensselaer, NY 12144, USA.
Paul J KempSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
Nicholas D AllenSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
Ernest FraenkelDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Leslie M ThompsonDepartment of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA 92697, USA; Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA; Department of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biological Chemistry, University of California Irvine, Irvine, CA 92617, USA. Electronic address: lmthomps@uci.edu.
University of California, Irvine · USMassachusetts Institute of Technology · USCardiff University · GBNeural Stem Cell Institute · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells-SupplementU54NS091046 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI FINKBEINER, STEVEN M, FRAENKEL, ERNEST · 2014 to 2020
$11.7M
Training in the Neurobiology of Aging and Alzheimers DiseaseT32AG000096 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI VIVEK SWARUP, Craig E Stark · 1985 to 2026
$9.6M
Epigenetic Pathology and Therapy in Huntington's DiseaseR01NS089076 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FRAENKEL, ERNEST, HOUSMAN, DAVID · 2015 to 2024
$4.9M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
The Huntington's disease (HD) IPS consortiumU24NS078370 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI THOMPSON, LESLIE MICHELS · 2012 to 2013
$2.6M
Medical Research Council MR/L023784/1Medical Research Council MR/L023784/2NCI NIH HHS P30 CA062203NIA NIH HHS T32 AG000096NIEHS NIH HHS P30 ES002109NINDS NIH HHS R01 NS089076NINDS NIH HHS U24 NS078370NINDS NIH HHS U54 NS091046
6 · The paper itself

Abstract

Aberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude of neurological disorders, including Huntington's disease (HD). However, the mechanism underlying this potential pathology remains unclear. We used a modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients and unaffected controls into neuronal cultures enriched for medium spiny neurons, the cell type most affected in HD. We performed single-cell and bulk transcriptomic and epigenomic analyses and demonstrated that a persistent cyclin D1

Indexed as

Wnt Signaling PathwayAdultAge of OnsetCell CycleCell DifferentiationCells, CulturedEpigenesis, GeneticHumansHuntington DiseaseInduced Pluripotent Stem CellsMitosisNeostriatumNeural Stem CellsNeuronsTranscription FactorsTranscriptomeTranscription Factorsadult-onset HDcell cycledevelopmentHuntington's diseaseinduced pluripotent stem cellsmedium spiny neuronsneural stem cellssingle-cell RNA-seqWNT signaling

Identifiers

PMID32109367
PMCPMC7066322
OpenAlexW3008955037

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.